Craig Erickson, M.D.

Craig A. Erickson, M.D. Assistant Professor of Psychiatry
Personal Statement	I am interested in clinical research involving persons with fragile X syndrome (FXS). FXS is the most common inherited form of developmental disability and most common known cause of autism. Our FXS clinic draws patients from throughout the Midwest. Currently, our clinic is involved in multiple FXS-specific therapeutic treatment trials. I staff several resident and fellow clinics per week and regularly give lectures related to developmental disorders to medical students, residents, and fellows.
Education	Undergraduate: DePauw University Medical School: University of Cincinnati College of Medicine Residency: Indiana University School of Medicine Fellowship: Indiana University School of Medicine Board Ceritifications/Certifications go here: Diplomate, American Board of Psychiatry and Neurology-General Psychiatry Diplomate, American Board of Psychiatry and Neurology-Child and Adolescent Psychiatry
Current Academic Interests	Clinical: Targeted therapeutic treatment of fragile X syndrome. Research: Psychopharmacology of interfering symptoms associated with pervasive developmental disorders.
Recent Publications	Erickson CA, Posey DJ, Stigler KA, Mullett J, Katschke AR, McDougle CJ (2007): A retrospective study of memantine in children and adolescents with pervasive developmental disorders. Psychopharmacology, 191, 141-147. Erickson CA, Stigler KA, Posey DJ, McDougle CJ (2007): The psychopharmacology of fragile X syndrome. International Drug Therapy Newsletter, 42, 35-42. Erickson C.A., Mullett J.E., McDougle, C.J.: Open-label pilot trial of memantine in fragile X syndrome. J Autism Dev Disord, in press.